SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 3 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $635,072 | +90.4% | 5,239 | +79.8% | 0.02% | +81.8% |
| Q2 2023 | $333,597 | +52270.0% | 2,913 | -37.0% | 0.01% | -45.0% |
| Q1 2023 | $637 | +69.4% | 4,623 | +59.5% | 0.02% | +25.0% |
| Q4 2022 | $376 | -99.4% | 2,899 | +397.3% | 0.02% | +1500.0% |
| Q3 2022 | $65,000 | -94.6% | 583 | -96.4% | 0.00% | -96.3% |
| Q2 2022 | $1,199,000 | +23.2% | 15,986 | +28.4% | 0.03% | +200.0% |
| Q1 2022 | $973,000 | +70.4% | 12,455 | +96.5% | 0.01% | -10.0% |
| Q4 2021 | $571,000 | +202.1% | 6,339 | +210.4% | 0.01% | +100.0% |
| Q3 2021 | $189,000 | -50.9% | 2,042 | -58.8% | 0.01% | -50.0% |
| Q2 2021 | $385,000 | +442.3% | 4,951 | +419.5% | 0.01% | +900.0% |
| Q1 2021 | $71,000 | -89.8% | 953 | -76.6% | 0.00% | -95.2% |
| Q4 2020 | $694,000 | -4.4% | 4,070 | -21.3% | 0.02% | +162.5% |
| Q3 2020 | $726,000 | +1016.9% | 5,169 | +1176.3% | 0.01% | +166.7% |
| Q2 2020 | $65,000 | -48.0% | 405 | -58.2% | 0.00% | -70.0% |
| Q4 2019 | $125,000 | +166.0% | 970 | +55.2% | 0.01% | +233.3% |
| Q3 2019 | $47,000 | +4600.0% | 625 | +8828.6% | 0.00% | – |
| Q1 2019 | $1,000 | -96.2% | 7 | -97.0% | 0.00% | -100.0% |
| Q4 2018 | $26,000 | -29.7% | 237 | +3.0% | 0.00% | -33.3% |
| Q3 2018 | $37,000 | +1133.3% | 230 | +277.0% | 0.00% | – |
| Q4 2017 | $3,000 | +50.0% | 61 | +38.6% | 0.00% | – |
| Q3 2017 | $2,000 | -98.5% | 44 | -99.1% | 0.00% | -100.0% |
| Q4 2016 | $132,000 | +76.0% | 4,811 | +293.1% | 0.01% | +100.0% |
| Q3 2016 | $75,000 | +257.1% | 1,224 | +9.6% | 0.01% | +250.0% |
| Q2 2016 | $21,000 | – | 1,117 | – | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2015 | $14,000 | -82.7% | 353 | -85.9% | 0.00% | -75.0% |
| Q3 2015 | $81,000 | +326.3% | 2,498 | +298.4% | 0.01% | +300.0% |
| Q2 2015 | $19,000 | -82.2% | 627 | -92.2% | 0.00% | -84.6% |
| Q1 2015 | $107,000 | +1428.6% | 8,045 | +1633.8% | 0.01% | +1200.0% |
| Q4 2014 | $7,000 | +250.0% | 464 | +293.2% | 0.00% | – |
| Q4 2013 | $2,000 | -97.0% | 118 | -91.5% | 0.00% | -100.0% |
| Q3 2013 | $66,000 | -25.8% | 1,390 | -40.6% | 0.01% | 0.0% |
| Q2 2013 | $89,000 | – | 2,341 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |